| Literature DB >> 28377953 |
Yujia Long1, William D Leslie2, Yunhua Luo1.
Abstract
The currently available clinical tools have limited accuracy in predicting hip fracture risk in individuals. We investigated the possibility of using normalized cortical bone thickness (NCBT) estimated from the patient's hip DXA (dual energy X-ray absorptiometry) as an alternative predictor of hip fracture risk. Hip fracture risk index (HFRI) derived from subject-specific DXA-based finite element model was used as a guideline in constructing the mathematical expression of NCBT. We hypothesized that if NCBT has stronger correlations with HFRI than the single risk factors such as areal BMD (aBMD), then NCBT can be a better predictor. The hypothesis was studied using 210 clinical cases, including 60 hip fracture cases, obtained from the Manitoba Bone Mineral Density Database. The results showed that, in general HFRI has much stronger correlations with NCBT than any of the single risk factors; the strongest correlation was observed at the superior side of the narrowest femoral neck with r2 = 0.81 (p < 0.001), which is much higher than the correlation with femoral aBMD, r2 = 0.50 (p < 0.001). The capability of aBMD, NCBT, and HFRI in discriminating the hip fracture cases from the non-fracture ones, expressed as the area under the curve with 95% confidence interval, AUC (95% CI), is respectively 0.627 (0.593-0.657), 0.714 (0.644-0.784) and 0.839 (0.787-0.892). The short-term repeatability of aBMD, NCBT, and HFRI, measured by the coefficient of variation (CV, %), was found to be in the range of (0.64-1.22), (1.93-3.41), (3.10-4.16), respectively. We thus concluded that NCBT is potentially a better predictor of hip fracture risk.Entities:
Keywords: Areal bone mineral density (aBMD); Cortical bone thickness; Dual energy X-ray absorptiometry (DXA); Hip fracture; Osteoporosis
Year: 2015 PMID: 28377953 PMCID: PMC5365175 DOI: 10.1016/j.bonr.2015.02.003
Source DB: PubMed Journal: Bone Rep ISSN: 2352-1872
Fig. 1(a) Hip CTXA projected from QCT scans by QCT Pro; Femur cross-section and the corresponding aBMD profile at (b) the femoral neck (AB), (c) the intertrochanter (CD), and (d) the femoral shaft (EF).
Fig. 2Projection of circular composite cross-section of two densities.
Fig. 3Determining cortical bone thicknesses using BIT. (a) narrowest femoral neck; (b) intertrochanter; (c) femoral shaft.
Fig. 4Sample BIT analysis report of the intertrochanteric cross-section in Fig. 3(b).
Fig. 5The procedure of subject-specific DXA-based FEA. (a) Femur contour segmented from the patient's hip DXA; (b) a finite element mesh generated from the contour; (c) assignment of material properties; (d) application of loading/boundary conditions; (e) the three regions of interest (ROI) for assessing hip fracture risk; (f) fracture risk distribution.
Statistics of 210 clinical cases.
| Parameters | Mean (SD) | |
|---|---|---|
| 60 cases | 150 controls | |
| Age (years) | 69.2 (3.5) | 65.4 (9.3) |
| Height (in.) | 63.1 (2.3) | 62.7 (2.2) |
| Weight (lbs.) | 129.4 (29.7) | 144.8 (31.4) |
| Femoral neck aBMD (g/cm2) | 0.712 (0.059) | 0.806 (0.147) |
| Trochanteric aBMD (g/cm2) | 0.576 (0.068) | 0.669 (0.168) |
| Total hip aBMD (g/cm2) | 0.738 (0.066) | 0.843 (0.179) |
Average relative error (e, %) between CTXA and QCT-derived cortical bone thickness.
| Femoral neck | Intertrochanter | Shaft | All six locations | |||
|---|---|---|---|---|---|---|
| Inferior | Superior | Medial | Lateral | Medial | Lateral | |
| 5.76 | 7.95 | 6.18 | 8.13 | 5.03 | 5.74 | 6.51 |
Fig. 6Bland–Altman plot of QCT and DXA measured cortical bone thicknesses.
Fig. 7Correlation between CTXA and QCT-derived cortical bone thicknesses.
Correlations between HFRI and risk factors (r2, p-value).
| Fracture risk factors | Cortical bone thickness | Areal BMD | Body mass index (BMI) | Femoral neck axial length (FNAL) | Neck-shaft angle ( | |
|---|---|---|---|---|---|---|
| Medial/inferior | Lateral/superior | |||||
| Femoral Neck | − 0.39 | − 0.68 (< 0.001) | − 0.50 (< 0.001) | 0.32 (< 0.001) | 0.37 (< 0.001) | 0.34 (< 0.001) |
| Intertrochanter | − 0.36 (< 0.001) | − 0.60 (< 0.001) | − 0.43 (< 0.001) | 0.27 (< 0.001) | 0.35 (< 0.001) | 0.28 (< 0.001) |
| Femoral shaft | − 0.35 (< 0.001) | − 0.57 (< 0.001) | − 0.22 (< 0.001) | 0.25 (< 0.001) | 0.33 (< 0.001) | 0.31 (< 0.001) |
A negative sign indicates a negative correlation.
Correlations between hip fracture risk index (HFRI) and normalized cortical bone thickness (NCBT), (r2, p-value).
| Femoral neck | Inferior | − 0.63 |
| Superior | − 0.81 (< 0.001) | |
| Intertrochanter | Medial | − 0.70 (< 0.001) |
| Lateral | − 0.75 (< 0.001) | |
| Femur shaft | Medial | − 0.60 (< 0.001) |
| Lateral | − 0.67 (< 0.001) |
A negative sign indicates a negative correlation.
AUC (95% CI) of aBMD, NCBT and HFRI.
| Hip fracture risk indicator | AUC | 95% CI | |
|---|---|---|---|
| Femoral neck BMD | 0.625 | 0.593–0.657 | |
| HFRI (at femoral neck) derived from DXA-based FE model | 0.839 | 0.787–0.892 | |
| NCBT at femoral neck | Superior | 0.714 | 0.644–0.784 |
| Inferior | 0.706 | 0.634–0.778 | |
Fracture risk indicators in cases and controls [Mean (SD)].
| Fracture risk indicator | 60 cases | 150 controls | Relative difference (%) | |
|---|---|---|---|---|
| aBMD | 0.712 (0.084) | 0.806 (0.147) | 12.4 | |
| CBT | Superior (mm) | 1.881 (0.292) | 2.133 (0.373) | 12.6 |
| Inferior (mm) | 3.193 (0.544) | 3.410 (0.581) | 6.6 | |
| NCBT | Superior (10− 3) | 0.340 (0.079) | 0.433 (0.135) | 24.1 |
| Inferior (10− 3) | 0.573 (0.122) | 0.687 (0.204) | 18.1 | |
| HFRI | 1.628 (0.357) | 1.054 (0.456) | 42.8 | |
Short-term repeatability (CV, %) of areal BMD.
| Femoral neck | Trochanteric region | Proximal femur |
|---|---|---|
| 1.22 | 0.85 | 0.64 |
Short-term repeatability (CV, %) of NCBT.
| Narrowest femoral neck | Intertrochanter | Femoral shaft | |||
|---|---|---|---|---|---|
| Medial | Lateral | Medial | Lateral | Medial | Lateral |
| 3.27 | 3.41 | 2.59 | 2.85 | 1.93 | 2.38 |
Short-term repeatability (CV, %) of HFRI.
| Femoral neck | Intertrochanteric | Femoral shaft |
|---|---|---|
| 3.10 | 3.94 | 4.16 |
Correlations between femoral neck axis length (FNAL) and femur width (r2, p-value).
| Femoral neck width | Intertrochanteric width | Subtrochanteric width | |
|---|---|---|---|
| Femoral neck axis length | 0.32 (< 0.001) | 0.14 (< 0.001) | 0.17 (< 0.001) |